Skip to main navigation Skip to search Skip to main content

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases

  • Danielle K. DePalo
  • , Michelle M. Dugan
  • , Syeda Mahrukh Hussnain Naqvi
  • , David W. Ollila
  • , Tina J. Hieken
  • , Matthew S. Block
  • , Winan J. van Houdt
  • , Michel W.J.M. Wouters
  • , Sophie J.M. Reijers
  • , Nethanel Asher
  • , Kristy K. Broman
  • , Zoey Duncan
  • , Matilda Anderson
  • , David E. Gyorki
  • , Hayden Snow
  • , Jenny Held
  • , Jeffrey M. Farma
  • , John T. Vetto
  • , Jane Y.C. Hui
  • , Madison Kolbow
  • Robyn P.M. Saw, Serigne N. Lo, Georgina V. Long, John F. Thompson, Youngchul Kim, Lilit Karapetyan, Lars Ny, Alexander C.J. van Akkooi, Roger Olofsson Bagge, Jonathan S. Zager
  • Moffitt Cancer Center
  • University of North Carolina at Chapel Hill
  • Mayo Clinic
  • Netherlands Cancer Institute
  • Rabin Medical Center Israel
  • University of Alabama at Birmingham
  • U.S. Department of Veterans Affairs
  • Peter Maccallum Cancer Centre
  • University of Melbourne
  • Fox Chase Cancer Center
  • Oregon Health and Science University
  • University of Minnesota Twin Cities
  • University of Sydney
  • Royal North Shore and Mater Hospitals
  • Royal Prince Alfred Hospital
  • Sahlgrenska University Hospital
  • University of Gothenburg

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Search results